人类的体力表现和粉样β:观察性研究的系统审查和元分析
Patricio Solis-Urra1,2,3, María Rodriguez-Ayllon4, Miriam Álvarez-Ortega1
1Department of Physical Education and Sports, Faculty of Sport Sciences, Sport and Health University Research Institute (iMUDS), University of Granada, Granada, Spain.
Journal of Alzheimer's disease : JAD
|November 26, 2023
概括
身体表现似乎与大脑,脑脊液或血液中的β-粉样蛋白 (Aβ) 积累无关. 需要更多的研究来证实这种在阿尔茨海默病 (AD) 中的关联.
科学领域:
- 神经学 神经学
- 老年学是指老年学的学科.
- 生物化学 生化学
背景情况:
- 阿尔茨海默病 (AD) 的特点是粉样β (Aβ) 斑块的积累.
- 身体表现与痴呆风险和Aβ相关,可能影响Aβ积累.
- 之前没有任何人类证据综合研究探讨过这种关系.
研究的目的:
- 为了研究身体表现和人类的Aβ之间的关联.
- 为了检查Aβ在大脑,脑脊液 (CSF) 和血液中的积累.
- 综合现有关于这种关系的证据.
主要方法:
- 进行了系统性审查和多层次元分析.
- 包括到2022年6月16日发表的研究.
- 符合条件的研究测量了身体表现作为预测因素和Aβ水平作为人类的结果.
主要成果:
- 分析了7篇与2619名参与者的文章.
- 身体表现和Aβ在大脑 (ES = 0.01),脑脊液 (ES = -0.28) 或血液 (ES = -0.19) 中没有发现显著的关联.
- 显著的异质性和有限数量的研究对一致的结论提出了挑战.
结论:
- 身体表现与人类的Aβ之间的关联仍然没有确定性.
- 有限的研究,设计变化和测量异质性导致不确定性.
- 需要进一步的研究来确定身体表现和Aβ水平之间的关系.
相关概念视频
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Alzheimer's Disease: Overview
494
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
494


